- Home
- AUPH vs CXM Comparison
AUPH vs CXM Comparison
Compare AUPH & CXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | CXM |
|---|---|---|
| Founded | 1993 | 2009 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 1999 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AUPH | CXM |
|---|---|---|
| Price | $14.22 | $5.50 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 9 |
| Target Price | ★ $17.25 | $9.89 |
| AVG Volume (30 Days) | 836.9K | ★ 2.5M |
| Earning Date | 02-26-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 180.38 |
| EPS | ★ 0.55 | 0.42 |
| Revenue | $265,808,000.00 | ★ $839,147,000.00 |
| Revenue This Year | $21.76 | $8.25 |
| Revenue Next Year | $16.45 | $3.44 |
| P/E Ratio | $25.87 | ★ $12.93 |
| Revenue Growth | ★ 20.62 | 6.48 |
| 52 Week Low | $6.55 | $5.26 |
| 52 Week High | $16.54 | $9.69 |
Technical Indicators
Market Signals| Indicator | AUPH | CXM |
|---|---|---|
| Relative Strength Index (RSI) | 44.56 | 24.54 |
| Support Level | $14.21 | $5.26 |
| Resistance Level | $14.66 | $6.04 |
| Average True Range (ATR) | 0.43 | 0.26 |
| MACD | -0.00 | -0.05 |
| Stochastic Oscillator | 25.20 | 15.14 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About CXM Sprinklr Inc.
Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.